Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer
Clinical trial NCT03832361 · RECRUITING
Trial details
- NCT number
- NCT03832361
- Sponsor
- Alessandro Santin
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-15
- Primary completion
- 2026-10-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.